Amanuel Atamo

Amanuel Atamo

Auto-generated profile, based on publicly available information

Amanuel Atamo

Department of Environmental Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
CDChala Daba
Chala Daba
AAAmanuel Atamo
Amanuel Atamo
SDSisay Abebe Debela
Sisay Abebe Debela
EKEdosa Kebede
Edosa Kebede
LWLebasie Woretaw
Lebasie Woretaw
MGMesfin Gebrehiwot
Mesfin Gebrehiwot
Background: Regardless of various prevention and control strategies, malaria continues to be a significant public health problem in Ethiopia. As there are few studies on malaria trend analysis in Northeastern Ethiopia, it hinders the evaluation of ongoing and prioritization of new malaria intervention strategies, particularly during the period of pandemics. Therefore, the present study investigated the trend of malaria prevalence in Northeastern Ethiopia from 2015 to 2020. Methods: An institution-based retrospective study was employed to assess the trend of malaria prevalence over a 6-year period (2015– 2020) in three districts (Jile tumuga, Aruma fursi, and Dawachefa) of Northeastern Ethiopia. Data were extracted from clinical records of malaria cases by trained medical laboratory technologists. The associations between the prevalence of malaria and independent variables (age group, malaria transmission season, and districts) were assessed using chi-square test. P-values with a cut-off point of 0.05 were used to determine statistically significant associations. Results: In our study area, a total of 212,952 malaria suspected patients were diagnosed over the 6 years. Of these, 33,005 (15.5%) were confirmed malaria cases. The identified Plasmodium species were Plasmodium falciparum and P. vivax, accounting for 66.4% and 33.6%, respectively. These with the age of > 15 years old were the most affected (41.9%). The highest numbers of malaria cases (34.6%) were recorded during spring season (September to November). The prevalence of Plasmodium species showed a significant association with age (X2=9.7; p=0.002), districts (X2=13.5; p< 0.001), and malaria transmission season (X2=16.5; p< 0.001). Conclusion: In our study area, P. falciparum is the dominant species. We noted that malaria remains a public health concern and fluctuates throughout the years. Therefore, national, regional, zonal, and district health bureaus should strengthen the ongoing and devise appropriate prevention and control strategies even during the period of pandemics.

1 May 2022 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
CDChala Daba
Chala Daba
LALechisa Asefa
Lechisa Asefa
HLHailu Lemma
Hailu Lemma
AAAmanuel Atamo
Amanuel Atamo
EKEdosa Kebede
Edosa Kebede
MGMesfin Gebrehiwot
Mesfin Gebrehiwot
Background: Elders and patients with chronic diseases are more vulnerable to coronavirus disease 2019 (COVID-19) infection. In Ethiopia, these groups of people are given vaccination priorities amongst others. However, there is limited information on the acceptance of COVID-19 vaccine among patients with chronic diseases. Therefore, this study aimed to assess the acceptance of COVID-19 vaccine and associated factors among patients with chronic diseases visiting public hospitals in West Guji zone (Ethiopia). Methods and Materials: Facility-based cross-sectional study was employed among 408 chronic disease patients visiting two public hospitals in Ethiopia from September to October 2021. Data was collected using structured questionnaire. Multivariable logistic regression was computed to identify factors associated with acceptance of COVID-19 vaccine. Independent variables with p-value less than 0.05 were considered statistically significantly associated with the acceptance of COVID-19 vaccine. Results: The acceptance of COVID-19 vaccine among patients with chronic diseases was 39.5% (95% CI: 35– 44). Factors positively associated with the acceptance of COVID-19 vaccine were age ≥ 40 years (AOR = 2.84; 95% CI: 1.53– 5.28), urban residence (AOR = 0.6; 95% CI: 0.38– 0.95), having upper respiratory tract infection (AOR = 1.32; 95% CI: 1.03– 2.8), previous COVID-19 infection (AOR = 2.1; 95% CI: 1.22– 3.47), having health insurance (AOR = 2.55; 95% CI: 1.23– 5.28), those not drinking alcohol (AOR = 1.95; 95% CI: 1.24– 3.06), those not chewing Khat (AOR = 2.01; 95% CI: 1.27– 3.2), and having good knowledge (AOR = 1.55; 95% CI: 1.03– 2.87) and positive attitude (AOR = 2.05; 95% CI: 1.26– 3.33) towards the vaccine. Conclusion: The overall proportion of COVID-19 vaccine acceptance is low among patients with chronic diseases. Therefore, to improve the acceptance of COVID-19 vaccine, the government and health professionals should provide continuous health education.